A Medical Device Daily

OSI Systems (Hawthorne, California) said that its healthcare division, Spacelabs Healthcare (Issaquah, Washington), has received a contract valued at $2.9 million from a Louisiana-based hospital to provide patient monitoring and telemetry solutions, which are expected to be installed throughout the hospital's care units.

OSI Systems CEO Deepak Chopra, said, “We are proud of the opportunity to provide healthcare solutions utilizing our latest technology for patient monitoring and telemetry data, including our newly released SL 3900 Dual Display Central Station and the Ultraview DM3 Dual Mode Vital Signs monitor.“

OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries.

In other agreements/contracts news:

• MDxHealth (Durham, North Carolina), a molecular diagnostics company in the field of personalized cancer treatment, has renewed its existing agreement with Veridex (Raritan, New Jersey) for the use of certain of its proprietary DNA methylation products in blood testing for colorectal cancer and prostate cancer screening. The transaction demonstrates MDxHealth's ability to deliver on its recently reported new strategy of developing and commercializing its DNA methylation products itself through a CLIA laboratory in the U.S. while out-licensing its methylation technology for cancer screening applications at an accelerated pace and as broadly as possible.

Under the revised agreement, the company grants Veridex non-exclusive rights for worldwide laboratory service testing to MDxHealth's DNA methylation biomarkers for use in blood-based detection of colorectal cancer, as well as tissue and urine-based detection of prostate cancer. In return, MDxHealth will receive milestone payments and royalties on net sales. Financial terms were not disclosed.

The new agreement replaces a broader agreement under which Veridex had exclusive rights to certain MDxHealth DNA methylation biomarkers for all resulting new products.

“This agreement demonstrates how quickly MDxHealth has been able to deliver on our new strategy. It greatly simplifies our contractual obligations and at the same time it could potentially provide revenues from future royalty streams from prostate and colorectal cancer screening applications developed by Veridex,“ said Jan Groen, CEO of MDxHealth.

• ITA Partners (Philadelphia), an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care, said that it has signed an agreement with Health Plan Select (Athens, Georgia) to implement its eviti solution to streamline system-wide processes for the delivery of high-quality, cost-effective care to cancer patients.

“Our goal is to ensure that our patients receive the appropriate care. eviti allows our oncologists to access the most up-to-date, comprehensive cancer care knowledge base available – in real time. And, because it also includes our plan language, we can provide approvals almost immediately, drastically reducing decision-making time,“ said Geoffrey Cole, medical director at Health Plan Select.

Health Plan Select operates health plans that cover nearly 24,000 members and offers a network of more than 1,000 physicians to businesses in 27 counties of northeast Georgia.

eviti is an independent, fully-integrated solution that simultaneously addresses the quality and cost concerns of cancer patients, oncologists and insurance companies, in any treatment setting. Patients benefit from appropriate treatment for their cancer; while physicians are empowered with systematic access to the latest, most comprehensive, evidence-based treatment standards, as well as the benefit of streamlined reimbursement, ITA said.

• Tenet Healthcare (Dallas) reported an agreement with Aetna Better Health of Pennsylvania that covers Hahnemann University Hospital and St. Christopher's Hospital for Children (both Philadelphia). The new agreement also covers physicians who are employed by subsidiaries of the two hospitals.

“This new agreement will allow us to provide high quality care to the members of Aetna Better Health,“ said Stephen Newman, MD, Tenet's COO. “Hahnemann University Hospital and St. Christopher's Hospital for Children now participate in all managed Medicaid programs that cover the Philadelphia area.“

Aetna Better Health, which began administering Medicaid benefits in Pennsylvania on April 1, 2010, serves more than 38,000 members in 15 counties in southeastern Pennsylvania and the Lehigh Valley/Capital areas. Tenet Healthcare is a health care services company whose subsidiaries and affiliates own and operate acute care hospitals, ambulatory surgery centers and diagnostic imaging centers.